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526a Tuesday, February 23, 2010activates NR1/NR2D (37%), but does not appear to activate NR1/NR2A
(~0%).
Single-channel recordings for NR1/NR2D expressed in HEK293 cells using
partial agonists (NH5PG, ethyl-, and propyl-NH5PG) and the full agonist
glutamate enable us to determine which states in the process of channel ac-
tivation can be modulated in an agonist-specific manner. These data show
that glutamate, NHP5G, ethyl-, and propyl-NH5PG have strikingly different
mean open times for NR1/NR2D (0.747, 0.432, 0.319, and 0.181 ms, re-
spectively). We are currently comparing the rate constants for activation
in models fitted to data from different partial agonists. We have also per-
formed molecular dynamics (MD) simulations of the agonist binding do-
mains for NR1/NR2A and NR1/NR2D bound with glutamate or propyl-
NHP5G to predict how the agonists interact differentially with receptor sub-
types. The synthesis of these lines of investigation will be used to identify
structural elements that can be modified using mutagenesis to test working
hypotheses on the structural basis for subunit-specific activation of NMDA
receptors.
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NMDA receptors are glutamate-gated ion-channels with high Ca2þ-perme-
ability, voltage-dependent block by extracellular Mg2þ, and slow gating ki-
netics. These intrinsic attributes are critical to coincidence detection and
synaptic plasticity at excitatory synapses in brain. The GluN1/GluN2A iso-
form (N1/N2A) predominates in adult brain; it has strong voltage-dependent
Mg2þ block and the fastest kinetics of all isoforms. In macroscopic mea-
surements, Mg2þ block generates a region of steep negative slope in the
current-voltage (I/V) relationship at membrane potentials negative to 50
mV. In single-channel current records, the binding of one Mg2þ ion pre-
cludes conduction by other cations and results in a discrete, resolvable
gap. In the presence of strong metal chelators (EDTA) and for receptors
that carry a single-residue substitution (N596G) in the N2A subunit (N1/
N2ANþ1G), the macroscopic I/V plot reverts to its normal linear shape
and the Mg2þ-dependent gap is absent from single-channel traces. To in-
vestigate whether the Nþ1G substitution in the pore impinges on the recep-
tor’s gating kinetics, we recorded single-channel current traces from cell-at-
tached patches of HEK-cells containing only one N1/N2ANþ1G receptor
and compared these with those recorded from wild-type receptors under
similar conditions. Measurements done in the absence of extracellular
Mg2þ (1 mM EDTA in the recording pipette) revealed that the Nþ1G sub-
stitution caused a ~2-fold decrease in activity (Po, 0.31 5 0.04, n ¼ 10 vs.
0.65 5 0.04, n ¼ 12 for wild-type, p < 0.001) due to ~2-fold shorter
openings and ~3-fold longer closures. Our results indicate that a perturbation
in the pore that was intended to render the channels less sensitive to block
by extracellular divalent cations also has a significant effect on the gating
of NMDA receptors.
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The a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) sub-
type of glutamate ion channel receptors plays an essential role in the mam-
malian brain activities such as memory and learning, whereas the excessive
receptor activation has been implicated in neurological diseases such as
stroke, epilepsy, and amyotrophic lateral sclerosis. Inhibitors against
AMPA glutamate receptors are drug candidates for a potential treatment
of these neurological diseases. Using systematic evolution of ligands by ex-
ponential enrichment (SELEX), we have successfully identified three differ-
ent classes of aptamers with nanomolar affinity against the GluR2Qflip re-
ceptor, a key AMPA receptor subunit that controls the calcium permeabilityand mediates excitotoxicity. One class is a group of competitive aptamers,
which we selected by using NBQX, a classic competitive inhibitor. The
highest potency or IC50 value for one of the aptamers in this class reached
30 nM, rivaling any exiting AMPA receptor inhibitors. We have also iden-
tified two other classes of aptamers that are differentially selective to dif-
ferent conformations of GluR2Qflip: one class uniquely inhibits the open-
channel conformation whereas the other inhibits the closed-channel confor-
mation. As an initial proof-of-principle experiment, our results suggest the
possibility of developing aptamers that are nanomolar affinity, water-soluble
and highly selective to both an AMPA receptor subunit and a unique recep-
tor conformation. These aptamers are therefore excellent water-soluble tem-
plates for design of better inhibitors and better drug candidates against
AMPA receptors.
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Members of the ionotropic glutamate receptor (iGluR) family (NMDA, AMPA,
and kainate receptors) are allosteric ligand-gated ion channels that mediate
synaptic plasticity in the mammalian nervous system. Crystal structures of
the two-lobed binding domains of these receptors suggest that ligand binding
causes the lobes to move toward one another like a clamshell closing. It has
also been proposed that the degree of closure is proportional to the degree of
receptor activation. Using nonsense suppression methodology to incorporate
unnatural amino acids, we have created a functional probe of ligand binding
and the subsequent clamshell closure. By altering the electronic (e.g., convert-
ing glutamate to nitrohomoalanine) and steric (e.g., converting tyrosine to
homotyrosine) properties of binding site residues of the NMDA and AMPA
receptors, we have been able to define the requirements for both full and partial
agonist binding and to confirm that agonist efficacy is related to the degree of
clamshell closure.2720-Pos
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Ionotropic glutamate receptors (iGluR’s) are ligand gated ion channels that
mediate most of the fast excitatory neurotransmission in the CNS. Aberrant
function of glutamate neurotransmission can lead to epilepsy and other neu-
rodegenerative disorders. The extracellular ligand binding domain is a bilo-
bal structure that binds an agonist and induces channel activation. Cell at-
tached patch recordings were performed with both full and partial agonists
on HEK 293 cells stably expressing homomeric GluR3-flip receptor chan-
nels. Single channel data were analyzed using QuB software to detect chan-
nel conductance states and to determine a simple model of agonist depen-
dent channel activity and underlying modal behavior. Amplitude analysis
uncovered three conductance states, 15 pS, 27 pS, and 40 pS, in the pres-
ence of the full agonist, glutamate, as well as the partial agonists, fluoro-
willardiine, chlorowillardiine and nitrowillardiine. Different modes of acti-
vation ranging from low to high open probability exist for this channel.
The dwell times for the high mode are longer compared to the low
mode. In the presence of the full agonist, glutamate, during a high mode
of activation, the channel prefers to open to the intermediate and large con-
ductance states. In the presence of the willardiine partial agonists, the chan-
nel opens more frequently to the smallest and intermediate conductance
states. Kinetic modeling using maximum interval likelihood rate optimiza-
tion revealed two time constants in each open state and at least three in
the closed state for the full and partial agonists. These data suggests that
the mechanisms of channel activation are similar for both full and partial
agonists but the transition rates between states differ. Supported by NIH
NS049223 and NS063518.
